ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 81.36M | $ 70.84M | $ 69.56M | $ 209.91M | $ 33.92M |
| Gross Profit | $ 73.68M | $ 64.89M | $ 67.03M | $ 206.61M | $ 32.52M |
| Operating Income | $ -108.38M | $ -130.65M | $ -165.99M | $ -123.34M | $ -261.72M |
| EBITDA | $ -106.50M | $ -102.65M | $ -145.83M | $ -107.70M | $ -230.53M |
| Net Income | $ -142.62M | $ -157.85M | $ -240.05M | $ -157.13M | $ -230.03M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 261.34M | $ 250.87M | $ 278.60M | $ 326.44M | $ 466.54M |
| Total Assets | $ 323.15M | $ 321.98M | $ 354.78M | $ 490.86M | $ 617.97M |
| Total Debt | $ 439.01M | $ 123.00M | $ 124.38M | $ 129.85M | $ 139.70M |
| Net Debt | $ 177.67M | $ -127.87M | $ -154.22M | $ -196.59M | $ -326.85M |
| Total Liabilities | $ 508.98M | $ 524.62M | $ 503.03M | $ 411.41M | $ 451.88M |
| Stockholders' Equity | $ -185.83M | $ -202.64M | $ -148.25M | $ 79.45M | $ 166.09M |
| Cash Flow | |||||
| Free Cash Flow | $ -141.44M | $ -124.70M | $ -121.90M | $ -139.00M | $ -239.75M |
| Operating Cash Flow | $ -141.17M | $ -123.83M | $ -118.69M | $ -138.31M | $ -233.38M |
| Investing Cash Flow | $ 395.00K | $ -867.00K | $ -3.22M | $ -687.00K | $ -6.67M |
| Financing Cash Flow | $ 150.94M | $ 97.05M | $ 73.88M | $ -897.00K | $ 267.39M |